SHCSotera Health Co
Services-Misc Health & Allied Services, NEC
- Revenue
- $1.2B
- 5.7% YoY
- Operating margin
- —
- EBITDA
- —
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- —
- $1.8B net debt
- AI in 10-K
- —
Red flags 0 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear368% of net incomeCash flow under 80% of net income
- Dilutive SBCClear3% of revenueOver 10% of revenue
- Payouts exceed cash flowClear0% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear33% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $931M | $1.0B | $1.0B | $1.1B | $1.2B | 5.7% |
| Operating income | $257M | $248M | $277M | $298M | — | |
| Net income | $116M | −$234M | $51M | $44M | $78M | 76% |
| Operating cash flow | $282M | $278M | −$148M | $224M | $287M | 28% |
| Capex | $102M | $182M | $215M | $179M | $138M | 23% |
| Stock-based comp | $14M | $21M | $32M | $37M | $31M | 16% |
| Buybacks | $0 | $0 | — | — | — | |
| Dividends | $0 | — | — | — | — |
Deal filings
None.
13D filers
None on file.
Insider trading
No open-market trades in the last 12 months.
Pay vs performance
| Year | CEO total comp | Comp actually paid | TSR (indexed) | Peer TSR |
|---|---|---|---|---|
| FY2025 | $11M | $17M | 64 | 148 |
| FY2024 | $10M | $5M | 54 | 136 |
| FY2023 | $10M | $31M | 67 | 132 |
| FY2022 | $17M | $6M | 33 | 130 |
| FY2021 | $2M | −$2M | 94 | 132 |